Legal & General Group Plc - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 51 filers reported holding TCR2 THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 20.14 and the average weighting 0.7%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$7,000
-36.4%
2,3810.0%0.00%
Q4 2021$11,000
-84.7%
2,381
-71.8%
0.00%
Q3 2021$72,000
+24.1%
8,435
+137.5%
0.00%
Q2 2021$58,000
-27.5%
3,552
-1.2%
0.00%
Q1 2021$80,000
-23.1%
3,594
+6.2%
0.00%
Q4 2020$104,000
+131.1%
3,385
+52.9%
0.00%
Q3 2020$45,000
+40.6%
2,214
+4.9%
0.00%
Q2 2020$32,000
+220.0%
2,110
+34.2%
0.00%
Q1 2020$10,000
-65.5%
1,572
-21.3%
0.00%
Q4 2019$29,0000.0%1,998
+2.1%
0.00%
Q3 2019$29,000
+262.5%
1,956
+258.9%
0.00%
Q2 2019$8,0005450.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
MPM BioImpact LLC 3,370,982$68,498,00016.50%
MPM ASSET MANAGEMENT LLC 4,050,865$82,314,00015.35%
Consonance Capital Management LP 1,509,819$30,680,0003.74%
Soleus Capital Management, L.P. 282,041$5,731,0003.04%
Redmile Group, LLC 2,793,288$56,760,0001.04%
PFM Health Sciences, LP 775,794$15,764,0000.73%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,200,000$24,384,0000.59%
Cormorant Asset Management, LP 600,000$12,192,0000.47%
Sofinnova Investments, Inc. 173,028$3,516,0000.26%
Artal Group S.A. 500,000$10,160,0000.25%
View complete list of TCR2 THERAPEUTICS INC shareholders